JP2011520456A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520456A5 JP2011520456A5 JP2011509855A JP2011509855A JP2011520456A5 JP 2011520456 A5 JP2011520456 A5 JP 2011520456A5 JP 2011509855 A JP2011509855 A JP 2011509855A JP 2011509855 A JP2011509855 A JP 2011509855A JP 2011520456 A5 JP2011520456 A5 JP 2011520456A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- timp
- top2a
- her2
- abnormality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200800696 | 2008-05-20 | ||
| DKPA200800696 | 2008-05-20 | ||
| US5494408P | 2008-05-21 | 2008-05-21 | |
| US61/054,944 | 2008-05-21 | ||
| PCT/DK2009/050116 WO2009140973A1 (en) | 2008-05-20 | 2009-05-20 | A combined method for predicting the response to an anti-cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520456A JP2011520456A (ja) | 2011-07-21 |
| JP2011520456A5 true JP2011520456A5 (https=) | 2012-07-05 |
Family
ID=40010544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509855A Pending JP2011520456A (ja) | 2008-05-20 | 2009-05-20 | 抗癌療法に対する応答を予測するための組み合わせ方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110144047A1 (https=) |
| EP (1) | EP2288729A1 (https=) |
| JP (1) | JP2011520456A (https=) |
| CN (1) | CN102099493A (https=) |
| AU (1) | AU2009250169A1 (https=) |
| CA (1) | CA2725171A1 (https=) |
| WO (1) | WO2009140973A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6841609B2 (ja) | 2015-07-10 | 2021-03-10 | ３スキャン インコーポレイテッド | 組織学的染色の空間的多重化 |
| CN105524990A (zh) * | 2015-12-30 | 2016-04-27 | 广州安必平医药科技股份有限公司 | Her-2基因和/或top2a基因检测探针及其制备方法和试剂盒 |
| CN105483255A (zh) * | 2015-12-30 | 2016-04-13 | 广州安必平医药科技股份有限公司 | Top2a基因检测探针及其制备方法和试剂盒 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2002014A1 (en) * | 2006-04-01 | 2008-12-17 | Dako Denmark A/S | Method for performing prognoses for high-risk breast cancer patients using top2a gene aberrations |
-
2009
- 2009-05-20 AU AU2009250169A patent/AU2009250169A1/en not_active Abandoned
- 2009-05-20 CN CN2009801284436A patent/CN102099493A/zh active Pending
- 2009-05-20 CA CA2725171A patent/CA2725171A1/en not_active Abandoned
- 2009-05-20 WO PCT/DK2009/050116 patent/WO2009140973A1/en not_active Ceased
- 2009-05-20 EP EP09749512A patent/EP2288729A1/en not_active Withdrawn
- 2009-05-20 US US12/993,372 patent/US20110144047A1/en not_active Abandoned
- 2009-05-20 JP JP2011509855A patent/JP2011520456A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Del Vecchio et al. | Next-generation sequencing: recent applications to the analysis of colorectal cancer | |
| Saito et al. | Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non–small cell lung cancer | |
| CN108350504B (zh) | 膀胱癌的诊断方法 | |
| US20200199684A1 (en) | Method for prognosis of renal cell carcinoma | |
| US12351876B2 (en) | Colon cancer methylation markers and uses thereof | |
| US12359258B2 (en) | Lung cancer methylation markers and uses thereof | |
| US12359257B2 (en) | Liver cancer methylation markers and uses thereof | |
| Xia et al. | Racial/ethnic disparities in human DNA methylation | |
| JP2019528704A5 (https=) | ||
| US20190360052A1 (en) | Breast and ovarian cancer methylation markers and uses thereof | |
| US20150126376A1 (en) | Compositions and methods for sensitive mutation detection in nucleic acid molecules | |
| Sakamoto et al. | MT1G hypermethylation: a potential prognostic marker for hepatoblastoma | |
| Bethge et al. | Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma | |
| EP3481952A1 (en) | Leukemia methylation markers and uses thereof | |
| Hassan et al. | Genetic and epigenetic heterogeneity and the impact on cancer relapse | |
| Wang et al. | DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer | |
| CN111440863B (zh) | Kazn基因甲基化检测试剂在制备结直肠癌预后诊断试剂中的应用 | |
| Zhang et al. | RETRACTED ARTICLE: Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer | |
| Zabolotneva et al. | A systematic experimental evaluation of microRNA markers of human bladder cancer | |
| Wong et al. | Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer | |
| Kitkumthorn et al. | LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers | |
| Lopez et al. | Advances in biomarkers: going beyond the carcinoembryonic antigen | |
| Zhuo et al. | LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer | |
| CN102016067A (zh) | 前列腺癌中gstp1高甲基化的检测 | |
| JP2011520456A5 (https=) |